Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Vanguard FTSE All-World ex-US ETF
VEU
$71B
| $749K | ﹤0.01% |
13,781
-53,978
| -80% | -$3.01M |
|
2827
Bankwell Financial Group
BWFG
$524M
| $748K | ﹤0.01% |
23,181
+3,387
| +17% | +$113K |
|
|
MITL
2828
DELISTED
Mitel Networks Corporation
MITL
| $748K | ﹤0.01% |
80,551
-1,206,924
| -94% | -$10.6M |
|
|
NSLR
2829
Neostellar Capital Corp
NSLR
$272M
| $744K | ﹤0.01% |
117,547
+38,144
| +48% | +$242K |
|
|
TSE
2830
CALL
DELISTED
Trinseo
TSE
| $741K | ﹤0.01% |
+10,000
| New | +$788K |
|
|
OMED
2831
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $740K | ﹤0.01% |
232,774
-310,561
| -57% | -$856K |
|
2832
CALL
Insulet
PODD
$9.92B
| $737K | ﹤0.01% |
+8,500
| New | +$660K |
|
|
HABT
2833
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $737K | ﹤0.01% |
83,776
-106,854
| -56% | -$963K |
|
2834
Cytokinetics
CYTK
$10.8B
| $736K | ﹤0.01% |
102,172
+75,442
| +282% | +$647K |
|
2835
Spyre Therapeutics
SYRE
$9.47B
| $736K | ﹤0.01% |
2,968
+2,415
| +437% | +$436K |
|
2836
Marchex
MCHX
$79.8M
| $734K | ﹤0.01% |
268,759
-1,033
| -0.4% | -$3.34K |
|
|
BAND
2837
Bandwidth Inc
BAND
$1.5B
| $731K | ﹤0.01% |
22,396
-36,671
| -62% | -$936K |
|
|
GCI
2838
DELISTED
Gannett Co., Inc
GCI
| $731K | ﹤0.01% |
73,283
-1,437,696
| -95% | -$15.6M |
|
|
SGI
2839
Somnigroup International
SGI
$13.5B
| $730K | ﹤0.01% |
64,488
+45,012
| +231% | +$618K |
|
2840
Collegium Pharmaceutical
COLL
$852M
| $725K | ﹤0.01% |
28,388
-37,829
| -57% | -$901K |
|
2841
Merchants Bancorp
MBIN
$2.46B
| $725K | ﹤0.01% |
50,571
-19,689
| -28% | -$278K |
|
|
NAK
2842
Northern Dynasty Minerals
NAK
$1.01B
| $725K | ﹤0.01% |
800,024
-123,388
| -13% | -$148K |
|
|
EMD
2843
Western Asset Emerging Markets Debt Fund
EMD
$614M
| $719K | ﹤0.01% |
49,518
-135,984
| -73% | -$2.06M |
|
2844
SLB Ltd
SLB
$79.1B
| $719K | ﹤0.01% |
11,092
-76,359
| -87% | -$5.33M |
|
2845
Quanex
NX
$916M
| $716K | ﹤0.01% |
41,135
+31,588
| +331% | +$615K |
|
|
AKTS
2846
DELISTED
Akoustis Technologies Inc
AKTS
| $715K | ﹤0.01% |
122,668
-23,863
| -16% | -$149K |
|
2847
BlackRock Enhanced International Dividend Trust
BGY
$533M
| $712K | ﹤0.01% |
116,838
+74,395
| +175% | +$477K |
|
|
GOOS
2848
Canada Goose Holdings
GOOS
$803M
| $711K | ﹤0.01% |
21,269
-1,746
| -8% | -$58.7K |
|
2849
Superior Group of Companies
SGC
$201M
| $710K | ﹤0.01% |
27,008
+16,517
| +157% | +$421K |
|
|
SNBR
2850
DELISTED
Sleep Number
SNBR
| $710K | ﹤0.01% |
20,205
-24,353
| -55% | -$891K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.